InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.18+0.01 (+0.85%)
Close on Nov 16, 2026Market cap $85.31MP/E –Yield –
InflaRx total assets
Total assets on the balance sheet at the end of each period.
InflaRx's total assets was €55.22M at Dec 31, 2025. For fiscal 2025 it was €55.22M, down 27.4% from the year before. The highest annual figure on record is €159.21M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €55.22M | -27.4% |
| FY2024 | Dec 31, 2024 | €76.02M | -36.8% |
| FY2023 | Dec 31, 2023 | €120.21M | +17.4% |
| FY2022 | Dec 31, 2022 | €102.40M | -18.2% |
| FY2021 | Dec 31, 2021 | €125.14M | +41.9% |
| FY2020 | Dec 31, 2020 | €88.22M | -27.4% |
| FY2019 | Dec 31, 2019 | €121.58M | -23.6% |
| FY2018 | Dec 31, 2018 | €159.21M | +28.2% |
| FY2017 | Dec 31, 2017 | €124.21M | +320.8% |
| FY2016 | Dec 31, 2016 | €29.52M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €55.22M | -54.1% |
| Q2 FY2025 | Jun 30, 2025 | €73.44M | -44.8% |
| Q4 FY2024 | Dec 31, 2024 | €76.02M | -25.8% |
| Q2 FY2024 | Jun 30, 2024 | €93.04M | -18.8% |
| Q4 FY2023 | Dec 31, 2023 | €120.21M | -3.9% |
| Q2 FY2023 | Jun 30, 2023 | €132.96M | +50.7% |
| Q4 FY2022 | Dec 31, 2022 | €102.40M | -15.8% |
| Q2 FY2022 | Jun 30, 2022 | €114.63M | -20.9% |
| Q4 FY2021 | Dec 31, 2021 | €125.14M | -21.4% |
| Q4 FY2020 | Dec 31, 2020 | €88.22M | -29.0% |
| Q4 FY2019 | Dec 31, 2019 | €121.58M | +311.9% |
| Q2 FY2019 | Jun 30, 2019 | €144.92M | – |
| Q4 FY2018 | Dec 31, 2018 | €159.21M | – |
| Q4 FY2017 | Dec 31, 2017 | €124.21M | – |
| Q4 FY2016 | Dec 31, 2016 | €29.52M | – |
See a number that looks wrong?